← Leaderboards
Michael A Repka
University Of Mississippi Medical Center
$917,205
Attributed
$917,205
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $256.9K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$917,205 · 5
By mechanism
P20$917,205 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Mississippi Medical Center
Same institution · by research overlap
- Deborah J Konkle-Parker$10,853,292
- Joey P. Granger$19,512,927
- Raouf A. Khalil$9,732,738
Others in their field
Top investigators on “Prodrugs”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Robert Turner Schooley · University Of Colorado Denver$47,231,917
- Lynn Kirkpatrick · Ensysce Biosciences, Inc.$26,039,397
- David Heimbrook · Leidos Biomedical Research, Inc.$21,781,988
- Kevin V Grimes · Stanford University$14,783,804
Research focus
ProdrugsLeadDosage FormsGrantIn VitroAnimal ModelAnorexiaAdverse EffectsBiologicalGelatinAcquired Immunodeficiency SyndromeBiological AvailabilityComputer Retrieval Of Information On Scientific Projects DatabaseDesire For FoodFundingCapsule (Pharmacologic)Centers Of Research ExcellenceDrug KineticsChemotherapyEvaluation/TestingExhibitsChronically IllClinical ApplicationInstitution
Grant awards (6)
MISSISSIPPI COBRE: P 2: THC PRO-DRUGS FOR ORAL TRANSMUCOSAL DELIVERY$191,114
P20 · FY2009 · RR · contact PI
MISSISSIPPI COBRE: P 2: THC PRO-DRUGS FOR ORAL TRANSMUCOSAL DELIVERY$196,764
P20 · FY2008 · RR · contact PI
MISSISSIPPI COBRE: P 2: THC PRO-DRUGSFOR ORAL TRANSMUCOSAL DELIVERY$199,987
P20 · FY2007 · RR · contact PI
MISSISSIPPI COBRE: P 2: THC PRO-DRUGSFOR ORAL TRANSMUCOSAL DELIVERY$256,920
P20 · FY2006 · RR · contact PI
THC PRO-DRUGS IN TRANSMUCOSAL PATCH DELIVERY-NEUROPATHOLOGICAL CONDITIONS$34,274
P20 · FY2005 · RR
THC PRO-DRUGS IN TRANSMUCOSAL PATCH DELIVERY-NEUROPATHOLOGICAL CONDITIONS$38,146
P20 · FY2004 · RR